-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Shanghai, October 15, 2021 /PRNewswire/ - October 14 news, Xunbaihui Biotechnology Co.
Xunbaihui combines functional genomics and AI to develop new cancer immune antibody drugs
The meeting of hundred veins reaches the whole body
Relying on two core technology platforms, Xunbaihui’s first original antibody drug is aimed at a brand-new cancer immune checkpoint.
About Coatue
Coatue is one of the world's largest technology investment institutions, managing more than US$40 billion in assets
About Xunbaihui
Xunbaihui and its parent company GV20 Oncotherapy were established in 2016.
Source: Xunbaihui